AR

Amrita Roy

Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Viatris- Healthcare Company, Sumandeep Vidyapeeth UGC College

ORCID iD 0009-0007-4991-0602

About

As a Pharmaceutics Ph.D. scholar with a deep passion for cancer and nanotechnology research, my journey has been guided by an unwavering commitment to making a difference in the lives of cancer patients. From the very beginning of my academic pursuit, I have been captivated by the immense potential of pharmaceuticals in revolutionizing cancer treatment, and my focus has been on harnessing the power of nanotechnology to create cutting-edge drug delivery systems.

My current Ph.D. research is centered around designing and optimizing novel drug carriers that can precisely deliver therapeutic agents to specific tumor sites, while sparing healthy tissues from unwanted toxicity. By engineering nanoparticles and stimuli-responsive drug carriers, I aim to strike a delicate balance between effective treatment and reduced side effects, ultimately striving to improve patients' quality of life during their battle against cancer. Throughout my academic journey, I have delved deep into the complexities of pharmaceutics, diving into the realms of pharmacokinetics, drug formulation, and nanocarrier development.

Beyond the laboratory, I actively engage in scientific communities, seizing opportunities to attend conferences and workshops. These interactions not only enrich my knowledge but also foster valuable collaborations with fellow researchers. Additionally, I find immense joy in extracurricular activities like painting and music.

Employment

  • Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education Junior Research Fellow
    2022 - Present
  • Viatris- Healthcare Company Assistant Manager
    2021 - 2022

Education

  • Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education M.Pharm
    2019 - 2021
  • Sumandeep Vidyapeeth UGC College B.Pharm
    2016 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (4)